miR-107 modulates EMT progression of OSCC by targeting SNCG and inhibiting the ERK/NF-κB signaling pathways
Authors:
Open Access
- 7 August 2025
- journal article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 881
Abstract
Oral squamous cell carcinoma (OSCC) is marked by aggressive metastasis and poor prognosis, with epithelial-mesenchymal transition (EMT) serving as a pivotal process in tumor metastasis. Consequently, identifying critical targets and elucidating the underlying mechanisms that drive OSCC metastasis are vital for enhancing patient prognosis. This study sought to clarify the significance and underlying molecular mechanisms of the miR-107/synuclein gamma (SNCG) axis in the regulation of OSCC migration, invasion, and EMT progression. Peripheral blood from 26 OSCC patients and 24 controls assessed miR-107 expression, with GEO analysis for clinical significance. The effects of miR-107 and SNCG on OSCC migration, invasion and EMT in vivo and in vitro were assessed via wound healing, Transwell assays, qRT-PCR, WB and xenograft model. miR-107 was downregulated, while SNCG was upregulated in OSCC tissues. miR-107 served as a direct regulator of SNCG, leading to its downregulation. Gain- and loss-of-function studies demonstrated that SNCG promoted OSCC cell migration, invasion and EMT progression, while miR-107 inhibited EMT and exerted the opposite effect. These findings were confirmed in a nude mouse model, where miR-107 counteracted SNCG-induced tumor growth and EMT progression. Mechanistically, SNCG increased ERK1/2 and NF-κB p65 phosphorylation without altering total protein levels, while miR-107 mimic partially reversed these effects, suggesting that the miR-107/SNCG axis regulates migration, invasion and EMT progression through the ERK1/2 and NF-κB pathways. Overall, our findings elucidated that miR-107 attenuated migration and EMT in OSCC by targeting SNCG and inhibiting the ERK1/2/NF-κB pathway, providing novel potential therapeutic targets for OSCC.Keywords
Funding Information
- National Natural Science Foundation of China (81560473)
- Guangdong Basic and Applied Basic Research Foundation (2024A1515010858)
- Zhanjiang High-Level Hospital Construction Project (2021A05155)
- Central People's Hospital of Zhanjiang Startup Project for Doctoral Research (2022A08)
This publication has 43 references indexed in Scilit:
- Outcome Analysis of Patients With Oral Cavity Cancer and Extracapsular Spread in Neck Lymph NodesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigenBMC Cancer, 2010
- MicroRNAs as regulators of epithelial-mesenchymal transitionCell Cycle, 2008
- A Double-Negative Feedback Loop between ZEB1-SIP1 and the microRNA-200 Family Regulates Epithelial-Mesenchymal TransitionCancer Research, 2008
- A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cellsEMBO Reports, 2008
- The Prognostic Impact of Extent of Bone Invasion and Extent of Bone Resection in Oral CarcinomaThe Laryngoscope, 2008
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2Genes & Development, 2008
- Neuronal protein synuclein γ predicts poor clinical outcome in breast cancerInternational Journal of Cancer, 2007
- Synuclein-γ Targeting Peptide Inhibitor that Enhances Sensitivity of Breast Cancer Cells to Antimicrotubule DrugsCancer Research, 2007
- Molecular pathology of head and neck cancer.2002